Drug Shortage Report for AURO-QUETIAPINE
Report ID | 97204 |
Drug Identification Number | 02390256 |
Brand name | AURO-QUETIAPINE |
Common or Proper name | Quetiapine |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 & 500 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-23 |
Estimated end date | |
Actual end date | 2019-11-25 |
Shortage status | Resolved |
Updated date | 2019-11-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-11-27 | French | Compare |
v5 | 2019-11-27 | English | Compare |
v4 | 2019-10-24 | French | Compare |
v3 | 2019-10-24 | English | Compare |
v2 | 2019-10-24 | French | Compare |
v1 | 2019-10-24 | English | Compare |
Showing 1 to 6 of 6